EUVIMEDEUVIMED entdecken
Crossref

Ermiao San attenuating rheumatoid arthritis via PI3K/AKT/mTOR signaling activate HIF-1α induced glycolysis

Yumeng Zhang, Haizhu Jin, Wenyue Jia, Yuqi Liu, Yuru Wang, Shuyan Xue, Yang Liu, Huiqin Hao

Journal of Ethnopharmacology · 2025-04 · 345 · 119615

DOI: 10.1016/j.jep.2025.119615 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025-04. Verfasst von Yumeng Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shanxi University of Chinese Medicine, Jinzhong, 030619, China; Basic Laboratory of Integrated Traditional Chinese and Western Medicine, Shanxi Unive…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Hypoxia-Inducible Factor 1, alpha Subunit, Drugs, Chinese Herbal, Arthritis, Experimental. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: As a classic formula, Ermiao San (EMS) characterized by its less medicinal flavor and strong potency had been proven to be effective and safe in the treatment of rheumatoid arthritis (RA) during clinical experience and our previous research. AIM OF THE STUDY: The therapeutic characteristics of multi-component and multi-target of traditional Chinese medicine prompted us to further investigated the effective compounds of EMS, and evaluated its potential mechanisms in treating RA. MATERIALS AND METHODS: Ultra-high-performance liquid chromatography high-resolution mass spectrometry (UPLC-HRMS) was used to analyze the primary absorption components of EMS in rat serum, with secondary mass spectrometry used to assist in identifying the structures of the compounds. Open field experiments, H&E staining, safranin-O-turquoise staining, ELISA, and other methods were applied to verify the alleviating effects of EMS on exercise capacity, inflammation, and cartilage damage in CIA rats. The RA-FLS model was established using TNF-α, and observed the effects of EMS on cell migration and invasion were observed through wound healing and transwell assays. In addition, immunohistochemistry and western blotting were employed to investigate the PI3K/AKT/mTOR/HIF-1α pathway both in vivo and in vitro. RESULTS: Seventeen compounds were identified in rat serum, which were considered as active ingredients involved in the improvement of RA by EMS. Furthermore, EMS demonstrated the outstanding anti-RA ability, as evidenced by the improvement in foot swelling and arthritis scores, alleviation of pathological changes in joint tissue, inhibition of inflammatory factors, and restoration of exercise ability. In vivo data showed that EMS reduced joint injury through the PI3K/AKT/mTOR/HIF-1α signaling pathway. In vitro studies indicated that TNF-α induced the expression of Glut1 and HK2 proteins, accelerated the glycolysis rate, and promoted migration and invasion of RA-FLS cells, leading to adverse outcomes. However, EMS regulated the expression of glycolysis-related molecules, HK2 and Glut1 through the PI3K/AKT/mTOR/HIF-1α pathway, thereby inhibiting inflammation, migration, and invasion of RA-FLS cells. CONCLUSION: The beneficial effects of EMS in CIA rats can be attributed to the inhibition of glycolysis in synovial fibroblasts via the PI3K/AKT/mTOR/HIF-1α pathway. This finding further enriches our understanding of the mechanisms by which EMS contributes to the treatment of RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidHypoxia-Inducible Factor 1, alpha SubunitDrugs, Chinese HerbalArthritis, ExperimentalAnimalsTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktSignal TransductionPhosphatidylinositol 3-KinasesRatsMaleRats, Sprague-DawleyGlycolysisHumansCell Movement

Stichwörter der Autor:innen

Ermiao SanGlycolysisPI3K/AKT/mTOR/HIF-1αRheumatoid arthritis

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktHypoxia-Inducible Factor 1, alpha SubunitDrugs, Chinese HerbalPhosphatidylinositol 3-KinasesmTOR protein, ratHif1a protein, rat

Autor:innen und Institutionen

  • Shanxi University of Chinese Medicine, Jinzhong, 030619, China; Basic Laboratory of Integrated Traditional Chinese and Western Medicine, Shanxi University of Chinese Medicine, Jinzhong, 030619, China; Engineering Resear…
  • Shanxi University of Chinese Medicine, Jinzhong, 030619, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Y., Jin, H., Jia, W., Liu, Y., Wang, Y., Xue, S., Liu, Y., & Hao, H. (2025). Ermiao San attenuating rheumatoid arthritis via PI3K/AKT/mTOR signaling activate HIF-1α induced glycolysis. Journal of Ethnopharmacology, 345, 119615. https://doi.org/10.1016/j.jep.2025.119615

Vancouver

Zhang Y, Jin H, Jia W, Liu Y, Wang Y, Xue S, et al. Ermiao San attenuating rheumatoid arthritis via PI3K/AKT/mTOR signaling activate HIF-1α induced glycolysis. Journal of Ethnopharmacology. 2025;345:119615. doi:10.1016/j.jep.2025.119615

BibTeX
@article{Zhang2025,
  author = {Zhang, Yumeng and Jin, Haizhu and Jia, Wenyue and Liu, Yuqi and Wang, Yuru and Xue, Shuyan and Liu, Yang and Hao, Huiqin},
  title = {Ermiao San attenuating rheumatoid arthritis via PI3K/AKT/mTOR signaling activate HIF-1α induced glycolysis},
  journal = {Journal of Ethnopharmacology},
  year = {2025},
  volume = {345},
  pages = {119615},
  doi = {10.1016/j.jep.2025.119615}
}
Kostenlos starten →